Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma Abou-Alfa, Ghassan K. , Shi, Qian , Knox, Jennifer J. ... - - JAMA Oncol - 2019 Manuscript - Primary - Primary - GI - CALGB-80802
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials André, Thierry , Meyerhardt, Jeffrey , Iveson, Timothy ... - - Lancet Oncol - 2020 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80702
Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance) Battaglin, Francesca , Ou, Fang-Shu , Qu, Xueping ... - ASCO - J. Clin. Oncol - 2020 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
New strategies to improve drug development in carcinoid tumors (Alliance A021202) Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - NETRF - - 2019 Abstract - No-Endpoint - Trial-Description-Only - GI - A021202
Randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202). Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - ASCO - J Clin Oncol - 2019 Abstract - Primary - Primary - GI - A021202
Randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202). Bergsland, Emily K. , Mahoney, Michelle R. , Asmis, Timothy R. ... - NANETS - Pancreas - 2019 Abstract - Primary - Primary - GI - A021202
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803 Bertagnolli, Monica M. , Niedzwiecki, Donna , Compton, Carolyn C. ... - - J Clin Oncol - 2009 Manuscript - Secondary - Primary - GI - CALGB-150705 , CALGB-89803
Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803 Bertagnolli, Monica M. , Redston, Mark , Compton, Carolyn C. ... - - J Clin Oncol - 2011 Manuscript - Primary - Primary - GI - C150705 , C89803 , C9581
p27Kip1 in Stage III Colon Cancer: Implications for Outcome Following Adjuvant Chemotherapy in CALGB 89803 Bertagnolli, Monica M. , Warren, Robert S. , Niedzwiecki, Donna ... - - Clin Cancer Res - 2009 Manuscript - Secondary - Primary - GI - CALGB-150705 , C89803
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206. Blum, Kristie A , Johnson, Jeffrey L , Niedzwiecki, Donna ... - - Leuk. Lymphoma - 2007 Manuscript - Primary - Primary - Lymphoma - CALGB-50206
Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153. Blum, Kristie A , Johnson, Jeffrey L , Niedzwiecki, Donna ... - - Cancer - 2006 Manuscript - Primary - Long-Term-Followup - Lymphoma - CALGB-9153
Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Brown, Justin C , Zhang, Sui , Niedzwiecki, Donna , Saltz, Leonard B ... - - JNCI Cancer Spectr - 2018 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-89803
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance) Brown, Justin C , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P ... - - JNCI Cancer Spectr - 2020 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405
Association of Family History with Cancer Recurrence and Survival Among Patients with Stage III Colon Cancer Chan, Jennifer A. , Meyerhardt, Jeffrey A. , Niedzwiecki, Donna ... - - JAMA - 2008 Manuscript - Secondary-not-in-original - Primary - GI - C89803
The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance) Cheng, En , Zhang, Sui , Ou, Fang-Shu , Mullen, Brian , Ng, Kimmie ... - - Cancer Epidemiol. Biomarkers Prev. - 2020 Manuscript - Secondary - Primary - GI - CALGB-89803
Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance) Cushman, Stephanie M. , Jiang, Chen , Hatch, Ace J. , Shterev, Ivo ... - - Clin. Cancer Res. - 2015 Manuscript - Secondary - Primary - GI - CALGB-80203
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901. Czuczman, Myron S , Porcu, Pierluigi , Johnson, Jeffrey ... - - Leuk. Lymphoma - 2007 Manuscript - Primary - Primary - Lymphoma - CALGB-59901
Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909 Damon, Lloyd E. , Johnson, Jeffrey L. , Niedzwiecki, Donna ... - - J Clin Oncol - 2009 Manuscript - Primary - Primary - Lymphoma - CALGB-59909
Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC) Das, Rahul K , Furchtgott, Leon , Meyerhardt, Jeffrey A. ... - ESMO - Ann Oncol - 2018 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
Bayesian machine learning on CALGB/SWOG 80405 (Alliance) and PEAK data identifies heterogeneous landscape of clinical predictors of overall survival (OS) in different populations of metastatic colorectal cancer (mCRC) Das, Rahul K , Ou, Fang-Shu , Washburn, Cecilia , Nixon, Andrew B. ... - ESMO GI - Annals of Oncology - 2019 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers Enzinger, Peter C. , Burtness, Barbara Ann , Niedzwiecki, Donna ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Primary - GI - CALGB-80403 , ECOG-1206
Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Fadelu, Temidayo , Zhang, Sui , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2018 Manuscript - Secondary - Primary - GI - CALGB-89803
Nut Consumption and Survival in Stage III Colon Cancer Patients: Results from CALGB 89803 (Alliance) Fadelu, Temidayo , Zhang, Sui , Niedzwiecki, Donna , Ye, Xing ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original - Primary - GI - CALGB-89803
Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance) Fuchs, Charles S. , Niedzwiecki, Donna , Mamon, Harvey J. ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - GI - CALGB-80101
Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) Fuchs, Michael A. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - PLoS ONE - 2014 Manuscript - Secondary - Primary - GI - CALGB-89803
Statistical modeling of CALGB 80405 (Alliance) to identify influential factors in metastatic colorectal cancer (CRC) dependent on primary tumor side. Furchtgott, Leon , Swanson, David , Hayete, Boris , Khalil, Iya ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Goel, Ajay , Nagasaka, Takeshi , Arnold, Christian N , Inoue, Toru ... - - Gastroenterology - 2007 Manuscript - Secondary - Primary - GI - CALGB-9865
Initial results of CALGB 80803: A randomized phase II trial of pet scan-directed combined modality therapy for esophageal cancer (Alliance) Goodman, Karyn A. , Niedzwiecki, Donna , Hall, Nathan ... - ASCO GI - J Clin Oncol - 2017 Abstract - Primary - Preliminary - GI - CALGB-80803
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration Grothey, Axel , Sobrero, Alberto F. , Meyerhardt, Jeffrey A. ... - ESMO - Annals of Oncology - 2017 Abstract - Secondary-not-in-original - Comprehensive - GI - CALGB-80702
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance) Guercio, Brendan J. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Prevention - C89803
Associations of Physical Activity with Survival and Progression in Metastatic Colorectal Cancer: Results from CALGB 80405 (Alliance) Guercio, Brendan J. , Venook, Alan P. , Niedzwiecki, Donna ... - ASCO GI - J Clin Oncol - 2017 Abstract - Secondary - Preliminary - GI - CALGB-80405
Associations of Insulin-Like Growth Factor Binding Proteins and Adiponectin with Disease Progression and Mortality in Metastatic Colorectal Cancer: Results from CALGB/SWOG 80405 (Alliance) Guercio, Brendan J. , Venook, Alan P. , Zhang, Sui , Ou, Fang-Shu ... - ASCO - J. Clin. Oncol. - 2019 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance) Guercio, Brendan J. , Zhang, Sui , Niedzwiecki, Donna , Li, Yanping ... - - PLoS ONE - 2018 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-89803
Body mass index, weight loss, and progression and mortality in metastatic colorectal cancer (Alliance) Guercio, Brendan J. , Zhang, Sui , Venook, Alan P. , Ou, Fang-Shu ... - AACR - Cancer Res - 2019 Abstract - Secondary - Primary - GI - CALGB-80405
Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. Guercio, Brendan J , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P ... - - J. Clin. Oncol. - 2019 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405 Guercio, Brendan J , Zhang, Sui , Ou, Fang-Shu , Venook, Alan P ... - - JNCI Cancer Spectr - 2020 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405
Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405 Guercio, Brendan J , Zhang, Sui , Venook, Alan P , Ou, Fang-Shu ... - - JNCI Cancer Spectr - 2020 Manuscript - Secondary - Primary - GI - CALGB-80405
Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) Hatch, Ace J. , Sibley, Alexander B. , Starr, Mark D. ... - - Cancer Med - 2016 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80203
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance). Hatch, Ace Joseph , Pang, Herbert , Starr, Mark D. , Brady, John C. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80203
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405 Heinemann, Volker , Niedzwiecki, Donna , Pearline, Rachel ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
An Initial Genetic Analysis of Gemcitabine-Induced High-Grade Neutropenia in Pancreatic Cancer Patients in CALGB 80303 (Alliance) Innocenti, Federico , Jiang, Chen , Sibley, Alexander B. ... - - Pharmacogenet. Genomics - 2019 Manuscript - Secondary - Primary - PPP - CALGB-80303
Genetic variation determines VEGF-A plasma levels in cancer patients Innocenti, Federico , Jiang, Chen , Sibley, Alexander B. ... - - Sci Rep - 2018 Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-80303
Causal modeling of CALGB 80405 (Alliance) identifies network drivers of metastatic colorectal cancer (CRC) Innocenti, Federico , Lenz, Heinz-Josef , Meyerhardt, Jeffrey ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome Innocenti, Federico , Ou, Fang-Shu , Qu, Xueping , Zemla, Tyler J. ... - - J. Clin. Oncol - 2019 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
Somatic DNA mutations, mutational load (ML), and MSI status: association with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance) Innocenti, Federico , Ou, Fang-Shu , Zemla, Tyler ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary - Primary - Correl Sci NOS - CALGB-80405
The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation Innocenti, Federico , Owzar, Kouros , Jiang, Chen , Etheridge, Amy S. ... - - PLoS ONE - 2018 Manuscript - Secondary-not-in-original - Primary - PPP - CALGB-80303
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405 Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original - Primary - PPP - CALGB-80405
A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405 Innocenti, Federico , Owzar, Kouros , Jiang, Chen ... - ECC - Eur J Cancer - 2015 Abstract - Secondary - Primary - PPP - CALGB-80405
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803 / ALLIANCE Jeon, Justin , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - Clin Colorectal Cancer - 2013 Manuscript - Secondary - Primary - Prevention - CALGB-89803
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). Kemeny, Nancy E , Niedzwiecki, Donna , Hollis, Donna R ... - - J. Clin. Oncol. - 2006 Manuscript - Primary - Primary - GI - CALGB-9481
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) Kindler, Hedy Lee , Niedzwiecki, Donna , Hollis, Donna ... - - J Clin Oncol - 2010 Manuscript - Primary - Primary - GI - CALGB-80303
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. Korn, Edward L , Liu, Ping-Yu , Lee, Sandra J ... - - J. Clin. Oncol. - 2008 Manuscript - Primary - Primary - Experimental - N9975
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: results from two prospective cohorts and CALGB 89803 Alliance) trial Kosumi, Keisuke , Hamada, Tsuyoshi , Zhang, Sui , Liu, Li ... - - Eur. J. Cancer - 2019 Manuscript - Secondary-not-in-original - Meta-Analysis - Correl Sci NOS - CALGB-89803
Randomized Phase II Study of Everolimus (E) versus Everolimus plus Bevacizumab (E+B) in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance) Kulke, Matthew H. , Niedzwiecki, Donna , Foster, Nathan R. ... - NANETS - Pancreas - 2016 Abstract - Primary - Primary - GI - CALGB-80701
Randomized Phase II Study of Everolimus Alone (E) versus Everolimus plus Bevacizumab (E+B) in Patients with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors, CALGB 80701 (Alliance) Kulke, Matthew H. , Niedzwiecki, Donna , Foster, Nathan R. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - GI - CALGB-80701
Randomized Phase II Study of Gemcitabine Administered at a Fixed Dose Rate or in Combination With Cisplatin, Docetaxel, or Irinotecan in Patients With Metastatic Pancreatic Cancer: CALGB 89904 Kulke, Matthew H. , Tempero, Margaret A. , Niedzwiecki, Donna ... - - J Clin Oncol - 2009 Manuscript - Primary - Primary - GI - CALGB-89904
Impact of Consensus Molecular Subtyping (CMS) on overall survival (OS) and Progression Free Survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance). Lenz, Heinz-Josef , Ou, Fang-Shu , Venook, Alan P. ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). Lenz, Heinz-Josef , Ou, Fang-Shu , Venook, Alan P ... - - J. Clin. Oncol. - 2019 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - A151425 , CALGB-80405
Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance) Li, Megan , Mulkey, Flora , Jiang, Chen , O'Neil, Bert H. ... - - Clin. Cancer Res. - 2018 Manuscript - Secondary-not-in-original - Meta-Analysis - PPP - CALGB-40502 , CALGB-80405 , CALGB-90401 , E5103
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer Mackintosh, Christopher , Yuan, Chen , Ou, Fang-Shu , Zhang, Sui ... - - JAMA Oncol - 2020 Manuscript - Secondary - Primary - GI - CALGB-80405
Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance) Malnassy, Greg , Geyer, Susan , Fulton, Noreen , Koval, Greg ... - - Blood - 2013 Abstract - Secondary-not-in-original - Meta-Analysis - Leuk Corr Sci - CALGB-10403 , CALGB-59909
A Phase II Trial of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma: Cancer and Leukemia Group B (CALGB) 80003 Mamon, Harvey J. , Niedzwiecki, Donna , Hollis, Donna ... - - Cancer - 2011 Manuscript - Primary - Primary - GI - CALGB-80003
Impact of smoking on patients with stage III colon cancer: Results from CALGB 89803 McCleary, Nadine Jackson , Niedzwiecki, Donna , Hollis, Donna ... - - Cancer - 2010 Manuscript - Secondary - Primary - GI - C89803
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the Cancer and Leukemia Group B (CALGB 9281). Meropol, Neal J , Niedzwiecki, Donna , Shank, Brenda ... - - J. Clin. Oncol. - 2008 Manuscript - Primary - Primary - GI - CALGB-9281
Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803 Meyerhardt, Jeffrey A. , Niedzwiecki, Donna , Hollis, Donna ... - - J Clin Oncol - 2008 Manuscript - Secondary - Primary - GI - C89803
Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702 Meyerhardt, Jeffrey A. , Shi, Qian , Fuchs, Charles S. ... - ASCO - JCO - 2020 Abstract - Primary - Primary - GI - CALGB-80702
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. Meyerhardt, Jeffrey A , Heseltine, Denise , Niedzwiecki, Donna ... - - J. Clin. Oncol. - 2006 Manuscript - Secondary - Primary - Prevention - CALGB-89803
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. Meyerhardt, Jeffrey A , Niedzwiecki, Donna , Hollis, Donna ... - - JAMA - 2007 Manuscript - Secondary - Primary - GI - CALGB-89803
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. Meyerhardt, Jeffrey A , Shi, Qian , Fuchs, Charles S , Meyer, Jeffrey ... - - JAMA - 2021 Manuscript - Primary - Primary - GI - CALGB-80702
Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). Morales-Oyarvide, Vicente , Yuan, Chen , Babic, Ana , Zhang, Sui ... - - J. Natl. Cancer Inst. - 2019 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-89803
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Andrew T. , Sato, Kaori ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary-not-in-original - Long-Term-Followup - Prevention - C89803
Multivitamin Use Is Not Associated With Cancer Recurrence or Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 Ng, Kimmie , Meyerhardt, Jeffrey A. , Chan, Jennifer A. ... - - J Clin Oncol - 2010 Manuscript - Secondary - Primary - GI - CALGB-8461 , CALGB-9665
Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803 Ng, Kimmie , Ogino, Shuji , Meyerhardt, Jeffrey A. ... - - J Natl Cancer Inst - 2011 Manuscript - Secondary - Primary - GI - C89803
Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB 80405 (Alliance) Ng, Kimmie , Venook, Alan P. , Sato, Kaori , Hollis, Bruce W. ... - ASCO GI - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - GI - CALGB-80405
Vitamin D status and survival of metastatic colorectal cancer patients: Results from CALGB/SWOG 80405 (Alliance) Ng, Kimmie , Venook, Alan P. , Sato, Kaori , Yuan, Chen ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - GI - CALGB-80405
Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581 Niedzwiecki, Donna , Bertagnolli, Monica M. , Warren, Robert S. ... - - J Clin Oncol - 2011 Manuscript - Primary - Primary - GI - C9581
Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance) Niedzwiecki, Donna , Frankel, Wendy L. , Venook, Alan P. , Ye, Xing ... - - J. Clin. Oncol - 2016 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150705 , C9581
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803 Niedzwiecki, Donna , Hasson, Rian M. , Lenz, Heinz‐Josef ... - - Oncologist - 2017 Manuscript - Secondary-not-in-original - Meta-Analysis - GI - C89803 , C9581
Blood-based biomarkers (BMs) in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI + bevacizumab (Bev), cetuximab (Cetux) or Bev + Cetux: Results from CALGB 80405 Nixon, Andrew B. , Sibley, Alexander B. , Hatch, Ace J. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603) O'Reilly, Eileen M. , Niedzwiecki, Donna , Hall, Margaret ... - - Oncologist - 2010 Manuscript - Primary - Primary - GI - CALGB-80603
Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial Ogino, Shuji , Liao, Xiaoyun , Imamura, Yu , Yamauchi, Mai ... - - J. Natl. Cancer Inst - 2013 Manuscript - Secondary - Primary - GI - CALGB-89803
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 Ogino, Shuji , Meyerhardt, Jeffrey A. , Irahara, Natsumi ... - - Clin Cancer Res - 2009 Manuscript - Secondary - Primary - GI - CALGB-150705 , CALGB-89803
MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial Pavelitz, Thomas , Renfro, Lindsay , Foster, Nathan R. ... - - PLoS ONE - 2014 Manuscript - Secondary - Primary - GI - CALGB-89803
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Posner, Mitchell C , Niedzwiecki, Donna , Venook, Alan P ... - - Ann. Surg. Oncol. - 2008 Manuscript - Primary - Primary - GI - CALGB-89903
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Romanus, Dorothy , Kindler, Hedy L , Archer, Laura , Basch, Ethan ... - - J Pain Symptom Manage - 2012 Manuscript - Secondary-not-in-original - Primary - Health Outcome - CALGB-80303
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. Ronellenfitsch, Ulrich , Jensen, Katrin , Seide, Svenja ... - - Eur. J. Cancer - 2019 Manuscript - Secondary-not-in-original - Meta-Analysis - GI - CALGB-9781
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. Saltz, Leonard B , Niedzwiecki, Donna , Hollis, Donna ... - - J. Clin. Oncol. - 2007 Manuscript - Primary - Primary - GI - C89803
Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405. Schrag, Deborah , Dueck, Amylou C. , Naughton, Michelle Joy ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary - Primary - Health Outcome - CALGB-70502 , CALGB-80405
Association of RAS mutations with race in metastatic colorectal cancer CALGB 80405 (Alliance) Sehdev, Amikar , Niedzwiecki, Donna , Venook, Alan P. ... - ASCO GI - J Clin Oncol - 2018 Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405
Prospective pooled analysis of six phase III trials investigating duration of adjuvant oxaliplatin-based therapy (3 versus 6 months) for patients with stage III colon cancer: The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration (Alliance) Shi, Qian , Sobrero, Alberto , Shields, Anthony , Yoshino, Takayuki ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80702
CpG Island Methylator Phenotype is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage 3 Colon Cancer Shiovitz, Stacey , Bertagnolli, Monica M. , Renfro, Lindsay A. ... - - Gastroenterology - 2014 Manuscript - Secondary - Primary - GI - CALGB-89803
Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Smith, Sonali M , Grinblatt, David , Johnson, Jeffrey L ... - - Br. J. Haematol. - 2008 Manuscript - Primary - Primary - Lymphoma - CALGB-50002
Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781 Tepper, Joel , Krasna, Mark J. , Niedzwiecki, Donna , Hollis, Donna ... - - J. Clin. Oncol. - 2008 Manuscript - Primary - Primary - GI - C9781
Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance) Van Blarigan, Erin L. , Fuchs, Charles S. , Niedzwiecki, Donna ... - - Cancer Epidemiol. Biomarkers Prev. - 2018 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-89803
Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis Van Blarigan, Erin L. , Fuchs, Charles S. , Niedzwiecki, Donna ... - - JAMA Oncol - 2018 Manuscript - Secondary - Primary - GI - CALGB-89803
Dietary fat intake after colon cancer diagnosis in relation to cancer recurrence and survival: CALGB 89803 (Alliance) Van Blarigan, Erin L. , Ou, Fang-Shu , Niedzwiecki, Donna ... - - Cancer Epidemiol. Biomarkers Prev. - 2018 Manuscript - Secondary - Primary - GI - CALGB-89803
Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial Van Blarigan, Erin L. , Zhang, Sui , Ou, Fang-Shu , Venlo, Alan ... - - JAMA Netw Open - 2020 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405
Diet quality and survival in metastatic colorectal cancer (CRC): data from CALGB/SWOG 80405 (Alliance) Van Blarigan, Erin L. , Zhang, Sui , Ou, Fang-Shu , Venook, Alan ... - AICR - - 2019 Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405
Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival CALGB 89803 (Alliance) Van Blarigan, Erin L , Fuchs, Charles S. , Niedzwiecki, Donna ... - ASCO GI - J Clin Oncol - 2017 Abstract - Secondary - Primary - GI - CALGB-89803
American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance) Van Blarigan, Erin L , Fuchs, Charles S. , Niedzwiecki, Donna ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary - Primary - GI - CALGB-89803
25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance) Van Loon, Katherine , Owzar, Kouros , Jiang, Chen , Kindler, Hedy L. ... - - J. Natl. Cancer Inst - 2014 Manuscript - Secondary - Primary - GI - CALGB-151006 , CALGB-80303
Impact of primary (1º) tumor location on overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance) Venook, Alan P. , Niedzwiecki, Donna , Innocenti, Federico ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - GI - CALGB-80405
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer Venook, Alan P. , Niedzwiecki, Donna , Lenz, Heinz-Josef ... - - JAMA - 2017 Manuscript - Primary - Primary - GI - CALGB-80405
CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). Venook, Alan P. , Niedzwiecki, Donna , Lenz, Heinz-Josef ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - GI - CALGB-80405
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581 Venook, Alan P. , Niedzwiecki, Donna , Lopatin, Margarita , Ye, Xing ... - - J. Clin. Oncol. - 2013 Manuscript - Secondary - Primary - GI - C9581 , C150705
Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance) Venook, Alan P. , Ou, Fang-Shu , Innocenti, Federico ... - ASCO - J. Clin. Oncol. - 2017 Abstract - Secondary - Primary - GI - CALGB-80405
Association of TP53 Mutational Status and Gender with Survival After Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803 Warren, Robert S. , Atreya, Chloe E. , Niedzwiecki, Donna ... - - Clin. Cancer Res. - 2013 Manuscript - Secondary - Primary - GI - CALGB-89803
Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance) Yuan, Chen , Sato, Kaori , Hollis, Bruce W. , Zhang, Sui ... - - Clin. Cancer Res. - 2019 Manuscript - Secondary-not-in-original - Primary - GI - CALGB-80405
